Nanopharmaceuticals Market
- 2026 年市場規模
- USD 1,89,000 Mn
- 2033 年預估規模
- USD 7,62,000 Mn
- 年複合成長率 CAGR
- 22.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Nanopharmaceuticals Market, By Carrier Type (Liposomes, Polymer, Nanocrystals, Inorganic, Protein, and Others), By Application (Oncology, Neurology, Anti-inflammatory, Anti-infective, Cardiovascular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Nanopharmaceuticals are novel medicine with particle size less than 1 micron, which work on the principle of nanotechnology. Nanopharmaceuticals are widely used in drug delivery as a carrier for therapeutic compound or as a therapeutic compound. Nanopharmaceuticals are designed to target particular cells, tissue or a specific organ.
Market Dynamics
Increasing prevalence of cardiovascular diseases, cancer, and infectious diseases are major factors driving nanopharmaceuticals market growth. The World Health Organization, factsheet September 2018, estimated around 10 million cases of tuberculosis and around 1.6 million deaths from the disease in 2017. Moreover, advantages of nanopharmaceuticals over macroscopic level medicines is expected to boost the market growth. Nanopharmaceuticals can pass the blood brain barrier and can access the remote areas of brain as well as low solubility of the compound can be developed for enhancing its characteristics.
Key features of the study
• This report provides in-depth analysis of the nanopharmaceuticals market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global nanopharmaceuticals market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Abbott, GlaxoSmithKline and plc., Eli Lilly and Company, Astrazeneca plc., Novavax, Inc., Stryker Corporation, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Tanabe Pharma Corporation, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma Inc., Navidea Biopharmaceuticals, Inc., AbbVie Inc., AMAG Pharmaceuticals, Amgen Inc., Astellas Pharma Inc., Celgene Corporation, Gilead Sciences, Inc., JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global nanopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the nanopharmaceuticals market
Market Segmentation
• By Carrier Type
o Liposomes
o Polymer
o Nanocrystals
o Inorganic
o Protein
o Others
• By Application
o Oncology
o Neurology
o Anti-inflammatory
o Anti-infective
o Cardiovascular
o Others
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Abbott
o GlaxoSmithKline plc.
o Eli Lilly and Company
o Astrazeneca plc.
o Novavax, Inc.
o Stryker Corporation
o OSI Pharmaceuticals
o Kadmon Pharmaceuticals
o Samyang Biopharm
o Mitsubishi Tanabe Pharma Corporation
o Kaken Pharmaceutical
o Selecta Biosciences
o Par Pharmaceutical
o Cerulean Pharma Inc.
o Navidea Biopharmaceuticals, Inc.
o AbbVie Inc.
o AMAG Pharmaceuticals
o Amgen Inc.
o Astellas Pharma Inc.
o Celgene Corporation
o Gilead Sciences, Inc.
o JOHNSON & JOHNSON
o Merck & Co., Inc.
o Novartis AG
o Pfizer, Inc.
o Hoffmann-La Roche AG
o Sanofi S.A
o Shire Plc.
o Teva Pharmaceuticals Industries Limited
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Carrier Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o Reimbursement Scenario
o Epidemiology
o Pest Analysis
o Regulatory Scenario
o New Product Launches
o Collaborations and Agreements
o Market Trends
4. Global Nanopharmaceuticals Market, By Carrier Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Liposomes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Polymer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Nanocrystals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Inorganic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Protein
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Nanopharmaceuticals Market, By Application, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Anti-inflammatory
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Anti-infective
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Nanopharmaceuticals Market, By Distribution Channel, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Nanopharmaceuticals Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
o North America
Market Size and Forecast, By Carrier Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Carrier Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Carrier Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Carrier Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
Market Size and Forecast, By Carrier Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Carrier Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Abbott Laboratories
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GlaxoSmithKline plc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Eli Lilly and Company
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Astrazeneca plc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novavax, Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Stryker Corporation
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
OSI Pharmaceuticals
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Kadmon Pharmaceuticals
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Samyang Biopharm
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Mitsubishi Tanabe Pharma Corporation
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Kaken Pharmaceutical
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Selecta Biosciences
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Par Pharmaceutical
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cerulean Pharma Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Navidea Biopharmaceuticals
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AbbVie Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AMAG Pharmaceuticals
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Amgen Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Astellas Pharma Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Celgene Corporation
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Gilead Sciences, Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
JOHNSON & JOHNSON
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck & Co., Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis AG
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer, Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hoffmann-La Roche AG
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi S.A
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Shire Plc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Teva Pharmaceuticals Industries Limited.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們